AXGN|AxoGen Inc|Price:40.990|Chg%:0.04

More Details of AxoGen Inc Company

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

AxoGen Inc Info



Ticker SymbolAXGN

Company nameAxoGen Inc

IPO dateDec 17, 1986

CEODale (Michael Donald)

Number of employees451

Security typeOrdinary Share

Fiscal year-endDec 17

Address13631 Progress Blvd.

CityALACHUA

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code32615

Phone13864626817

Websitehttps://www.axogeninc.com/

Ticker SymbolAXGN

IPO dateDec 17, 1986

CEODale (Michael Donald)

Company Executives of AxoGen Inc



Name

Name/Position

Position

Shareholding

Change

Ms. Lindsey Hartley

Chief Financial Officer

65.15K

+6.77%

Mr. Jens Schroeder Kemp

Chief Marketing Officer

64.95K

-6.16%

Mr. Paul G. Thomas

Independent Chairman of the Board

10.06K

--

Mr. Erick Wayne Devinney

Chief Innovation Officer

--

Ms. Amy A. Mcbride-Wendell

Lead Independent Director

--

Mr. Alan M. Levine

Independent Director

--

Mr. John H. Johnson

Independent Director

--

Mr. William P. (Bill) Burke

Independent Director

--

Dr. Joseph (Adrian) Tyndall, M.D.

Independent Director

--

Mr. Marc A. Began

Executive Vice President, Chief Compliance Officer, General Counsel

--

Name

Name/Position

Position

Shareholding

Change

Ms. Lindsey Hartley

Chief Financial Officer

65.15K

+6.77%

Mr. Jens Schroeder Kemp

Chief Marketing Officer

64.95K

-6.16%

Mr. Paul G. Thomas

Independent Chairman of the Board

10.06K

--

Mr. Erick Wayne Devinney

Chief Innovation Officer

--

Ms. Amy A. Mcbride-Wendell

Lead Independent Director

--

Mr. Alan M. Levine

Independent Director

--

Revenue Breakdown

FY2023

FY2022

Relevant data have not been disclosed by the company yet.

By RegionUSD

Name

Revenue

Proportion

United States

159.01M

0.00%

By Business

By Region

Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, May 10

Shareholders

Shareholder Types

Shareholders

Proportion

First Light Asset Management, LLC

6.19%

BlackRock Institutional Trust Company, N.A.

6.16%

Morgan Stanley & Co. LLC

4.56%

Vanguard Capital Management, LLC

4.31%

Wasatch Global Investors Inc

3.49%

Other

75.29%

Shareholders

Proportion

First Light Asset Management, LLC

6.19%

BlackRock Institutional Trust Company, N.A.

6.16%

Morgan Stanley & Co. LLC

4.56%

Vanguard Capital Management, LLC

4.31%

Wasatch Global Investors Inc

3.49%

Other

75.29%

Shareholder Types

Shareholders

Proportion

Investment Advisor/Hedge Fund

34.99%

Investment Advisor

32.71%

Hedge Fund

11.37%

Research Firm

6.91%

Individual Investor

2.31%

Private Equity

1.47%

Family Office

1.24%

Bank and Trust

0.51%

Pension Fund

0.46%

Other

8.02%

Institutional Shareholding



Updated: Wed, Apr 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2026Q1

399

48.71M

91.60%

+3.15M

2025Q4

342

42.08M

97.83%

+8.74K

2025Q3

350

42.06M

101.71%

+627.35K

2025Q2

344

41.40M

98.61%

+1.26M

2025Q1

339

40.15M

93.21%

-2.27M

2024Q4

327

37.35M

99.16%

-1.08M

2024Q3

305

37.98M

92.55%

+3.00M

2024Q2

285

37.71M

96.69%

+1.44M

2024Q1

290

36.54M

95.40%

-4.68M

2023Q4

299

34.97M

92.73%

+437.14K

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

First Light Asset Management, LLC

5.23M

10.08%

-572.40K

-9.86%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

3.27M

6.31%

+96.11K

+3.02%

Dec 31, 2025

Morgan Stanley & Co. LLC

2.43M

4.68%

+140.04K

+6.12%

Dec 31, 2025

Wasatch Global Investors Inc

923.57K

1.78%

-715.78K

-43.66%

Dec 31, 2025

ArrowMark Colorado Holdings, LLC

1.47M

2.84%

-484.12K

-24.72%

Dec 31, 2025

Assenagon Asset Management S.A.

1.38M

2.66%

+90.78K

+7.04%

Dec 31, 2025

Soleus Capital Management, L.P.

1.21M

2.33%

-519.70K

-30.10%

Dec 31, 2025

Geode Capital Management, L.L.C.

1.10M

2.11%

+16.15K

+1.50%

Dec 31, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

ROBO Global Healthcare Technology & Innovation ETF

3.51%

State Street SPDR S&P Health Care Equipment ETF

2.3%

iShares Neuroscience and Healthcare ETF

2.11%

Invesco Dorsey Wright Healthcare Momentum ETF

0.97%

Invesco NASDAQ Future Gen 200 ETF

0.74%

JPMorgan Fundamental Data Science Small Core ETF

0.21%

iShares Micro-Cap ETF

0.19%

Fidelity Enhanced Small Cap ETF

0.18%

Principal U.S. Small-Cap ETF

0.15%

Franklin US Small Cap Multifactor Index ETF

0.14%

ROBO Global Healthcare Technology & Innovation ETF

Proportion3.51%

State Street SPDR S&P Health Care Equipment ETF

Proportion2.3%

iShares Neuroscience and Healthcare ETF

Proportion2.11%

Invesco Dorsey Wright Healthcare Momentum ETF

Proportion0.97%

Invesco NASDAQ Future Gen 200 ETF

Proportion0.74%

JPMorgan Fundamental Data Science Small Core ETF

Proportion0.21%

iShares Micro-Cap ETF

Proportion0.19%

Fidelity Enhanced Small Cap ETF

Proportion0.18%

Principal U.S. Small-Cap ETF

Proportion0.15%

Franklin US Small Cap Multifactor Index ETF

Proportion0.14%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data